Palbociclib plus endocrine therapy in HR+/HER2- Advanced Breast Cancer patients: Interim Results of the PERFORM study 10. November 2023 Radosa J., Fietz T., Wilke J., Decker T., Petersen V., Deryal M., Knoblich J., Losem C., Rhein U., Schöttker B., Wrobel D., Pfeiler G., Zanucco E., Buncke J., Frank M., Woerner S.M., Gratzke, K., Adams, A., Glastetter E., Bartsch R., Lux M.P. Download Evaluation of the metastatic colorectal cancer score (mCCS) in predicting outcome for patients with RAS wild-type metastatic colorectal cancer treated with first-line panitumumab plus FOLFIRI/FOLFOX: Updated interim results of the non-interventional study VALIDATE Reiser M, Marschner N, Uhlig J, Jacobasch L, Müller L, Schuch A, Serrer L, de Buhr RK, Siebenbach HU, Göhler T, Schröder J, Semsek D,… Weiterlesen